Authors/Disclosures
|
|
No disclosure on file |
|
Elisa Canu
(Ospedale San Raffaele)
|
The institution of Elisa Canu has received research support from Italian Ministry of Health . |
|
Guido D. Vazquez II, PhD
(Neurociencias Favaloro)
|
Dr. Vazquez has nothing to disclose. |
|
Julia E. Thompson, MD
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Mateusz Makuch
|
No disclosure on file |
|
|
No disclosure on file |
|
Andrew Murchison
|
No disclosure on file |
|
Agustina Tamargo
|
No disclosure on file |
|
Analia Calle
|
Analia Calle has nothing to disclose. |
|
Kon Chu
(Seoul National University Hospital)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Alfredo Thomson, MD
(Favaloro Foundation)
|
Dr. Thomson has nothing to disclose. |
|
Michael D. Geschwind, MD, PhD, FAAN
(UCSF)
|
Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc.. |
|
Ernest R. Somerville, FRACP
|
No disclosure on file |